跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
FEDAC COMPOUND LINCTUS - HSA Drug Approval Details
Approvals
/
HSA
/
FEDAC COMPOUND LINCTUS
Approved
STANDARD
FEDAC COMPOUND LINCTUS
Unknown
🇸🇬 Health Sciences Authority
Approval Date
Jan 13, 2026
Approval ID
c010e2d9a7d71033
Company
Unknown
Type
Standard
Approval Details
Approval Id
c010e2d9a7d71033
Drug Name
FEDAC COMPOUND LINCTUS
Active Ingredients
PSEUDOEPHEDRINE HCl
30 mg/5 ml
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Jan 13, 2026
Approval ID
c010e2d9a7d71033
Type
Standard
Back to HSA Approvals